natco pharma semaglutide In a major step towards making advanced diabetes care more accessible, has announced the launch of generic injection in India, following approval from the Central Drugs Standard Control Organisation ( Natco Pharma partners with Eris

Semaglutide is classified as FDA Pregnancy Category: Not Assigned under the current labeling system (the previous letter category system was phased out)

Additionally, alarming signs such as severe abdominal pain, blood in your stool or signs of dehydrationlike a dry mouth, dizziness or reduced urinationshould prompt you to see your doctor. Semaglutide can have a significant impact on your life, but these gastrointestinal issues shouldnt prevent you from doing your daily activities and living your life

Therefore, its important to carefully discuss the risks and benefits of pregnancy on Ozempic with your doctor

Accessing GLP-1 weight loss treatment through the NHS can be difficult

According to the manufacturer of semaglutide, the concentration of the drug in the bloodstream typically reaches a steady level after 45 weeks of once-weekly use

The most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain